NYSE:CLX

Clorox Company (CLX)

96.56
+3.49 (3.75%)
as of Jul 10, 2026, 8:00:00 pm Market Open.
76 watching
0
Investor Insights
star iconJul 11, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Clorox Company, symbol CLX-N, is a dividend aristocrat that has faced various challenges in recent years, including a notable -11.83% decline this year and a 30% drop since the beginning of the year. The company's 5% dividend yield is a positive aspect, as it has a history of increasing dividends for 24 consecutive years, reflecting its commitment to shareholder returns. Analysts note its current trading at 17x PE, which is lower than historical valuations of 18-20x, suggesting potential upside. The normalization of supply chains and return to pre-war pricing in petrochemicals is encouraging, yet concerns over inflation and consumer preferences may impact their sales. The company’s earnings are finally finding a consistent upward trajectory, with expected growth of 6-8%, but its reliance on oil prices adds uncertainty amid geopolitical tensions.

consensus icon
Consensus
mixed
valuation icon
Valuation
undervalued
review icon
Similar
Procter&Gamble,PG
DON'T BUY

The Fair Market Value is 41% below the current price. It is currently trading at the Price to Book of 25X. This stock is simply not investment grade anymore.

HOLD

In a higher interest rate environment, you are starting to see opportunities for different kinds of returns. This is a very safe stock and grows slowly. Increases its dividend regularity. At this price, it is a little rich.

COMMENT

This has done well and they’ve had some positive earnings revisions. In the “staples” category it has a few things going right for it. It is a higher payor, so you get a nice dividend. Earnings growth should be in the high to mid single digits. The catch is, any valuation is quite rich. It’s come off a little since the peak, but staples, as a whole, is trading expensive. Interest rates going higher will put pressure on the stock.

BUY
You can’t go wrong. Canadian market has moved but US has not moved yet.
BUY
Has been performing quite well recently because of some improving revenue lines. Expects next year, 2nd quarter, to grow their revenues by 30%. P/E multiple is about 20 X, so not expensive. Should be a good solid performer.
TOP PICK
May be the subject of some corporate restructuring. Good consumer company.
Showing 31 to 36 of 36 entries